State Ledger
Company profile

Turn Therapeutics Inc. CIK 2023016

Ticker
TTRX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Westlake Village, CA 91362
Fiscal year end
2025 (FY)
Market Data
Close
$11.15
Change
-$0.71
Change %
-5.99%
Volume
2,543

TTRX · trading date Oct 12, 2026 · previous close $11.86 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$3.19M
Total assets
$12.16M
Total liabilities
$7.48M
Stockholders' equity
$4.69M
Cash & equivalents
$4.03M
Operating income
-$5.86M
Operating cash flow
-$2.56M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
61.5%
Equity / assets
38.5%
CapEx / revenue
—
Operating cash flow / net income
0.80×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$3.19M $12.16M $7.48M $4.69M
2024 — -$1.77M $2.05M $2.23M -$177.4K
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-10
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Westlake Village, CA 91362
250 NORTH WESTLAKE BLVD.
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:20 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies